Literature DB >> 29498001

Once Bitten Twice Shy: Thinking Carefully Before Adopting the EQ-5D-5L.

Jeff Round1.   

Abstract

Mesh：

Year:  2018        PMID： 29498001     DOI： 10.1007/s40273-018-0636-3

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  23 in total

1.  Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D.

Authors:  Brendan Mulhern; Clara Mukuria; Michael Barkham; Martin Knapp; Sarah Byford; Djøra Soeteman; John Brazier
Journal:  Br J Psychiatry       Date:  2014-05-22       Impact factor: 9.319

2.  EQ-5D-5L: Smaller steps but a major step change?

Authors:  John Brazier; Andrew Briggs; Stirling Bryan
Journal:  Health Econ       Date:  2018-01       Impact factor: 3.046

3.  EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom.

Authors:  Monica Hernandez Alava; Allan Wailoo; Sabine Grimm; Stephen Pudney; Manuel Gomes; Zia Sadique; David Meads; John O'Dwyer; Garry Barton; Lisa Irvine
Journal:  Value Health       Date:  2017-10-18       Impact factor: 5.725

4.  EQ-5D: Moving from Three Levels to Five.

Authors:  Andrew Lloyd
Journal:  Value Health       Date:  2017-12-06       Impact factor: 5.725

5.  Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.

Authors:  Fatima Al Sayah; Weiyu Qiu; Feng Xie; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2017-03-31       Impact factor: 4.147

Review 6.  EQ-5D for the assessment of health-related quality of life and resource allocation in children: a systematic methodological review.

Authors:  J Noyes; R T Edwards
Journal:  Value Health       Date:  2011-10-22       Impact factor: 5.725

7.  Agreement between health utility instruments in cochlear implantation.

Authors:  G G J Ramakers; Y E Smulders; A van Zon; V J C Kraaijenga; I Stegeman; G A Van Zanten; W Grolman
Journal:  Clin Otolaryngol       Date:  2016-02-12       Impact factor: 2.597

8.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

9.  Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer.

Authors:  Mahmood Yousefi; Safa Najafi; Shahram Ghaffari; Alireza Mahboub-Ahari; Hossein Ghaderi
Journal:  Iran Red Crescent Med J       Date:  2016-01-20       Impact factor: 0.611

10.  The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya.

Authors:  Anik R Patel; Richard T Lester; Carlo A Marra; Mia L van der Kop; Paul Ritvo; Lidia Engel; Sarah Karanja; Larry D Lynd
Journal:  Health Qual Life Outcomes       Date:  2017-07-17       Impact factor: 3.186
View more
  5 in total

Review 1.  A Review of Utility Measurement Methods Used in Pharmacoeconomic Submissions to HIRA in South Korea: Methodological Consistency and Areas for Improvement.

Authors:  Jihyung Hong; Eun-Young Bae
Journal:  Pharmacoeconomics       Date:  2021-07-28       Impact factor: 4.981

2.  A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT.

Authors:  Katherine Froggatt; Ashley Best; Frances Bunn; Girvan Burnside; Joanna Coast; Lesley Dunleavy; Claire Goodman; Ben Hardwick; Clare Jackson; Julie Kinley; Anne Davidson Lund; Jennifer Lynch; Paul Mitchell; Gareth Myring; Shakil Patel; Guillermo Perez Algorta; Nancy Preston; David Scott; Kate Silvera; Catherine Walshe
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

3.  Comparing the EQ-5D-3 L and EQ-5D-5 L: studying measurement and scores in Indonesian type 2 diabetes mellitus patients.

Authors:  Bustanul Arifin; Fredrick Dermawan Purba; Hendra Herman; John M F Adam; Jarir Atthobari; Catharina C M Schuiling-Veninga; Paul F M Krabbe; Maarten J Postma
Journal:  Health Qual Life Outcomes       Date:  2020-02-07       Impact factor: 3.186

4.  Psychometric properties of the EQ-5D-5L: a systematic review of the literature.

Authors:  You-Shan Feng; Thomas Kohlmann; Mathieu F Janssen; Ines Buchholz
Journal:  Qual Life Res       Date:  2020-12-07       Impact factor: 4.147

5.  NICE and the EQ-5D-5L: Ten Years Trouble.

Authors:  Chris Sampson
Journal:  Pharmacoecon Open       Date:  2021-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.